Anti-HBs Kit
Hepatitis B is a major global health issue, prevalent worldwide; its impact is most significant in the Western Pacific, African, and Eastern Mediterranean regions. Hepatitis B infection can be prevented through the use of a safe and effective vaccine that provides 98% to 100% protection. In adults who contract Hepatitis B, the infection becomes chronic in less than 5% of cases. In contrast, approximately 95% of those infected during infancy or early childhood develop chronic Hepatitis B; this underscores the importance of vaccinating infants and children. The presence of Anti-HBs antibodies is generally considered an indicator of immunity against Hepatitis B, following recovery from an infection with the Hepatitis B virus (HBV). Furthermore, individuals who have been successfully vaccinated also produce Anti-HBs antibodies against Hepatitis B.
Applications:
The Anti-HBs test is a rapid immunochromatographic assay designed for the qualitative detection of antibodies against the Hepatitis B surface antigen (HBsAg) in human serum, plasma, or whole blood samples.
• The presence of Anti-HBs typically indicates recovery and the development of immunity against Hepatitis B virus (HBV) infection.
• A positive Anti-HBs test result may also indicate that the individual has been vaccinated.

Performance Evaluation:
Sensitivity: 100%
Specificity: 100%